The global subcutaneous immunoglobulin (SCIg) market, valued at USD 11.22 billion in 2024, is anticipated to expand at a CAGR of 9.11% from 2025 to 2034, with growth increasingly driven by segment-wise performance across product types, administration methods, and therapeutic platforms. The market can be segmented by product type into liquid SCIg, lyophilized SCIg, and ready-to-use prefilled...
Romaian 
English
Arabic
French
Spanish
Portuguese
Deutsch
Turkish
Dutch
Italiano
Russian
Portuguese (Brazil)
Greek